Home › Compare › CRFTF vs DIVO

CRFTF vs DIVO: Dividend Comparison 2026

CRFTF yields 20000000.00% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRFTF wins by $4.875981653489057e+49M in total portfolio value
10 years
CRFTF
CRFTF
● Live price
20000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.875981653489057e+49M
Annual income
$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00
Full CRFTF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — CRFTF vs DIVO

📍 CRFTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRFTFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRFTF + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CRFTF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRFTF
Annual income on $10K today (after 15% tax)
$1,700,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, CRFTF beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRFTF + DIVO for your $10,000?

CRFTF: 50%DIVO: 50%
100% DIVO50/50100% CRFTF
Portfolio after 10yr
$2.4379908267445285e+49M
Annual income
$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRFTF buys
0
DIVO buys
0
No recent congressional trades found for CRFTF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRFTFDIVO
Forward yield20000000.00% ✓6.49%
Annual dividend / share$2.00$2.91 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.875981653489057e+49M$30.7K ✓
Annual income after 10y$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓$981.68
Total dividends collected$4.875978515990276e+49M$8.2K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CRFTF vs DIVO ($10,000, DRIP)

YearCRFTF PortfolioCRFTF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$2,000,010,700$2,000,000,000.00$11,349$649.42+$2000.00M → CRFTF
2$373,835,915,712,384$373,833,775,700,934.50$12,833$688.83+$373835915.70M → CRFTF
3$65,304,953,364,964,970,000$65,304,553,360,535,160,000.00$14,459$727.90+$65304953364964.95M → CRFTF
4$10,661,728,832,755,500,000,000,000$10,661,658,956,455,399,000,000,000.00$16,238$766.49+$10661728832755499008.00M → CRFTF
5$1,626,767,783,781,495,000,000,000,000,000$1,626,756,375,731,643,800,000,000,000,000.00$18,179$804.47+$1.626767783781495e+24M → CRFTF
6$231,974,330,054,625,100,000,000,000,000,000,000$231,972,589,413,096,470,000,000,000,000,000,000.00$20,293$841.71+$2.319743300546251e+29M → CRFTF
7$30,915,106,403,922,057,000,000,000,000,000,000,000,000$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00$22,591$878.14+$3.0915106403922057e+34M → CRFTF
8$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00$25,087$913.65+$3.8505079858392777e+39M → CRFTF
9$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00$27,791$948.18+$4.4821026103531426e+44M → CRFTF
10$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00$30,718$981.68+$4.875981653489057e+49M → CRFTF

CRFTF vs DIVO: Complete Analysis 2026

CRFTF — Stock

BC Craft Supply Co. Ltd. operates as a diversified life sciences company advancing cannabinoid and psychedelic innovation and psychotherapy. Its operations include CRFT, a curator and aggregator of craft cannabis, providing advocacy and access for premium small-batch growers to Canada's cannabis market; Medcann Health Products, a cultivation and processing facility in Chemainus providing access to Canadian medical and recreational cannabis markets; Feelwell Brands, a cannabinoid brand house licensed in the state of California; and AVA Pathways, a pre-clinical biotech company focuses on neuroplasticity and mental health applications using psilocybin and compounds derived from mushrooms. The company was formerly known as Pasha Brands Ltd. and changed its name to BC Craft Supply Co. Ltd. in May 2020. BC Craft Supply Co. Ltd. is based in Vancouver, Canada.

Full CRFTF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this CRFTF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRFTF vs SCHDCRFTF vs JEPICRFTF vs OCRFTF vs KOCRFTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.